Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David F. Claxton"'
Autor:
Todd E. Fox, Mark Kester, Hong Gang Wang, Shantu Amin, Charyguly Annageldiyev, Gemma Fabriàs, Jennifer M. Pearson, David J. Feith, Dhimant Desai, Thomas P. Loughran, José Luis Abad, Su Fern Tan, Myles C. Cabot, David F. Claxton, Arati Sharma
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Mol Cancer Res
instname
Mol Cancer Res
Acute myeloid leukemia (AML) is a disease characterized by uncontrolled proliferation of immature myeloid cells in the blood and bone marrow. The 5-year survival rate is approximately 25%, and recent therapeutic developments have yielded little survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a1bdd7205bbbd915f8f5818c777254c
http://hdl.handle.net/10261/212229
http://hdl.handle.net/10261/212229
Autor:
Brian M. Barth, Thomas P. Loughran, Krishne Gowda, Shantu Amin, Qiang Liu, Hong Gang Wang, David F. Claxton, Kenichiro Doi
Publikováno v:
Cancer Biology & Therapy. 15:1077-1086
Acute myeloid leukemia (AML) is one of the deadliest leukemias for which there is an urgent and unmet need for the development of novel treatment strategies. Multiple drug resistance mechanisms mediate poor drug response and relapse in patients, and
Autor:
Jong K. Yun, Dhimant Desai, Brian M. Barth, Thomas P. Loughran, Andy Awwad, Mark Kester, Hong Gang Wang, Stephen D. Turner, Xin Liu, Samy A.F. Morad, Edward H. Schuchman, Kenichiro Doi, David J. Feith, Arati Sharma, Ross L. Levine, Junjia Zhu, Todd E. Fox, Su Fern Tan, Alden Dewey, Myles C. Cabot, David F. Claxton, Barbara Spitzer, Mithun Vinod Shah, Shantu Amin, Jason Liao
Publikováno v:
Oncotarget
// Su-Fern Tan 1 , Xin Liu 2 , Todd E. Fox 3 , Brian M. Barth 4 , Arati Sharma 2 , Stephen D. Turner 5 , Andy Awwad 2 , Alden Dewey 2 , Kenichiro Doi 6 , Barbara Spitzer 7 , Mithun Vinod Shah 8 , Samy A.F. Morad 9, 10 , Dhimant Desai 11 , Shantu Amin
Autor:
Jianhong Zhang, Liuluan Zhu, W. Christopher Ehmann, Witold B. Rybka, Todd D. Schell, Melissa R. George, Yaxian Kong, David F. Claxton, Hong Zheng, Hui Zeng
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 22(12)
Purpose: T-cell immunoglobulin and immunoreceptor tyrosine–based inhibitory motif (ITIM) domain (TIGIT) is a recently identified T-cell coinhibitory receptor. In this study, we aimed to determine the clinical impact of TIGIT in patients with acute